A meta-analysis of pemetrexed-based doublet compared with pemetrexed alone for the second-line treatment of advanced non-small-cell lung cancer
Keyword(s):
Keyword(s):
Keyword(s):
2011 ◽
Vol 69
(1)
◽
pp. 99-106
◽
Keyword(s):
Keyword(s):
2012 ◽
Vol 138
(5)
◽
pp. 745-751
◽
Keyword(s):
2016 ◽
Vol 77
(3)
◽
pp. 485-494
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):